Cases 1 - 5 of 5
IN RE: INVOKANA (CANAGLIFLOZIN) PRODUCTS LIABILITY LITIGATION
as 3:2016md02750
Plaintiff:
MARIA PUENTE , CARLOS PUENTE , STELLA S. BENJAMIN and others
Defendant:
JANSSEN PHARMACEUTICALS, INC. , JOHNSON & JOHNSON CO. , MITSUBISHI TANABE PHARMA CORP. and others
Plaintiff_consolidated:
Charles Schenkenberger
Cause Of Action: 28 U.S.C. § 1332
KEMP v. JANSSEN PHARMACEUTICALS, INC. et al
as 3:2016cv05676
Plaintiff:
WILLIAM KEMP and TERESA KEMP
Defendant:
JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON CO. and MITSUBISHI TANABE PHARMA CORP.
Cause Of Action: 28 U.S.C. § 1332
Kemp et al v. Pfizer, Inc. et al
as 1:2015cv07388
Plaintiff:
William Kemp and Martha L Kemp
Defendant:
Pfizer, Inc. and Pharmacia & Upjohn Company Inc.
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
KEMP v. ARMSTRONG WORLD INDUSTRIES, INC. et al
as 2:2007cv68315
Plaintiff:
WILLIAM KEMP
Defendant:
ARMSTRONG WORLD INDUSTRIES, INC., ASBESTOS CLAIMS FACILITY, JOHN CRANE-HOUDAILLE and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Asbestos Litigation
Greene et al v. Novartis Pharmaceuticals et al
as 7:2007cv00091
Plaintiff:
William Kemp Greene, William Kemp Greene, Mary Carol Greene and others
Defendant:
Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation and others
Cause Of Action: 28 U.S.C. § 1441 Petition for Removal- Personal Injury
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
